 | Dicerna™ Appoints Patrick Gray to Board of Directors to Support Continued Growth
finance.yahoo.com - September 19 at 8:20 PM |
| How Should Investors Feel About Dicerna Pharmaceuticals, Inc.'s (NASDAQ:DRNA) CEO Pay?
finance.yahoo.com - September 18 at 1:31 PM |
 | Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Announce Quarterly Sales of $11.70 Million
www.americanbankingnews.com - September 12 at 5:57 AM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Expected to Post Earnings of -$0.27 Per Share
www.americanbankingnews.com - September 10 at 10:32 AM |
| Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 4 at 2:53 PM |
| Dicerna™ to Present at H.C. Wainwright 21st Annual Global Investment Conference
finance.yahoo.com - September 3 at 7:25 PM |
| 3 Biopharma Stocks With Over 50% Upside
finance.yahoo.com - September 3 at 9:29 AM |
| BioBoyScout’s Online Biotech Valuation Calculators Help Small Investors See Value in Arrowhead Pharmaceuticals (ARWR)
finance.yahoo.com - August 15 at 11:44 AM |
| Edited Transcript of DRNA earnings conference call or presentation 8-Aug-19 8:30pm GMT
finance.yahoo.com - August 13 at 10:27 PM |
 | Dicerna Pharmaceuticals Inc (DRNA) Q2 2019 Earnings Call Transcript
www.fool.com - August 9 at 9:58 PM |
 | Dicerna Pharmaceuticals EPS misses by $0.04, misses on revenue
seekingalpha.com - August 9 at 12:48 AM |
| Dicerna™ Reports Second Quarter 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - August 9 at 12:47 AM |
| Dicerna™ to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
finance.yahoo.com - August 1 at 11:42 PM |
| Dicerna's DCR-PHXC a Breakthrough Therapy for rare kidney disorder
seekingalpha.com - July 15 at 6:22 PM |
| Dicerna: An RNA Therapy-Based 21st Century Likely Winner
seekingalpha.com - July 12 at 8:48 AM |
| Dicerna to start clinical development of DCR-A1AT for liver disease
seekingalpha.com - July 2 at 8:52 AM |
| Dicerna™ to Begin Clinical Development of DCR-A1AT for Treatment of Patients with Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
finance.yahoo.com - July 2 at 8:52 AM |
| RNAi startup Dicerna developing new liver drug
finance.yahoo.com - July 2 at 8:52 AM |
| Dicerna reports additional data for DCR-PHXC in PH1 and PH2 patients
seekingalpha.com - June 21 at 11:08 AM |
| Dicerna™ Presents Additional Data from PHYOX™1 Study of DCR-PHXC in Patients with Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)
finance.yahoo.com - June 21 at 11:08 AM |
| Globally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary Hyperoxaluria
finance.yahoo.com - June 20 at 8:24 AM |
| Did The Underlying Business Drive Dicerna Pharmaceuticals's (NASDAQ:DRNA) Lovely 393% Share Price Gain?
finance.yahoo.com - June 18 at 3:51 PM |
| Did The Underlying Business Drive Dicerna Pharmaceuticals's (NASDAQ:DRNA) Lovely 393% Share Price Gain?
finance.yahoo.com - June 18 at 3:51 PM |
| Dicerna™ Hires Industry Veterans to Lead Regulatory Affairs and Patient Advocacy
finance.yahoo.com - June 13 at 8:20 AM |
| Bain's second life sciences fund comes in over $1 billion
finance.yahoo.com - June 12 at 5:05 PM |
| Here’s What Hedge Funds Think About Dicerna Pharmaceuticals Inc (DRNA)
finance.yahoo.com - June 12 at 11:25 AM |
| Dicerna™ Appoints Rob Ciappenelli Chief Commercial Officer
finance.yahoo.com - June 4 at 8:54 AM |
| Dicerna™ to Present at the Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 28 at 5:56 PM |
| Dicerna begins patient dosing in early-stage HBV study
seekingalpha.com - May 16 at 10:12 AM |
| Dicerna Announces Dosing of First Patient in Phase 1 Clinical Trial of DCR-HBVS for the Treatment of Chronic Hepatitis B Virus
finance.yahoo.com - May 16 at 10:11 AM |
| Dicerna Pharmaceuticals (DRNA) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 10 at 8:54 AM |
| Edited Transcript of DRNA earnings conference call or presentation 9-May-19 8:30pm GMT
finance.yahoo.com - May 10 at 8:54 AM |
| Dicerna Pharmaceuticals Inc (DRNA) Q1 2019 Earnings Call Transcript
www.fool.com - May 9 at 11:13 PM |
 | Dicerna™ Reports First Quarter 2019 Financial and Operating Results and Provides Corporate Update
www.businesswire.com - May 9 at 7:17 PM |
| Dicerna Pharmaceuticals misses by $0.16, misses on revenue
seekingalpha.com - May 9 at 7:17 PM |
| Dicerna™ to Report First Quarter 2019 Financial Results and Host Conference Call on May 9, 2019
finance.yahoo.com - May 2 at 7:38 PM |
| Dicerna™ Submits Updated IND Application for DCR-PHXC for Treatment of Primary Hyperoxaluria (PH) for the PHYOX™2 Pivotal Trial
finance.yahoo.com - May 2 at 8:55 AM |
| Dicerna™ to Present at the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - April 1 at 7:26 PM |
| Dicerna™ Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
finance.yahoo.com - April 1 at 7:26 PM |
| Dicerna reports updated data for DCR-PHXC in PH1 and PH2
seekingalpha.com - March 29 at 8:58 AM |
| Dicerna™ Announces the Presentation of Updated Data Demonstrating Utility of its Lead Compound DCR-PHXC in Treating Primary Hyperoxaluria Type 1 (PH1) and Type 2 (PH2)
finance.yahoo.com - March 29 at 8:58 AM |
| Edited Transcript of DRNA earnings conference call or presentation 11-Mar-19 8:30pm GMT
finance.yahoo.com - March 12 at 9:17 AM |
| Dicerna announces top 2019 milestones; shares down 2% after hours
seekingalpha.com - March 11 at 7:14 PM |
| Dicerna™ Reports Fourth Quarter and Year Ended December 31, 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - March 11 at 7:13 PM |
| Dicerna Pharmaceuticals: 4Q Earnings Snapshot
finance.yahoo.com - March 11 at 7:13 PM |
| Dicerna Pharmaceuticals (DRNA) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 11 at 7:13 PM |
 | New Research: Key Drivers of Growth for Energy Transfer LP, Domo, Accenture, Chevron, Cincinnati Financial, and Dicerna Pharmaceuticals — Factors of Influence, Major Initiatives and Sustained Production - GlobeNewswire
globenewswire.com - March 6 at 7:02 PM |
| Dicerna to Report Fourth Quarter and Year End 2018 Financial Results and Host Conference Call on March 11, 2019
finance.yahoo.com - March 4 at 7:24 PM |
| Dicerna Pharmaceuticals (DRNA) To Present At SVB Leerink 8th Global Healthcare Conference - Slideshow - Seeking Alpha
seekingalpha.com - March 3 at 8:33 AM |
| Dicerna Pharmaceuticals to Present at Upcoming Investor Conferences
finance.yahoo.com - February 22 at 6:41 PM |
